Search

Take a Behind-the-Scenes Tour of Our Residency Program Ophthalmology resident Dr. Inês Laíns provides an inside look at the Harvard Ophthalmology Residency Training Program, including the state-of-the-art clinical and educational facilities at Mass Eye and Ear. What Makes Our Program One of the Best...

Launched in the summer of 2021, the Harvard Ophthalmology Research Scholars Program offers first-year medical students from underrepresented and disadvantaged groups an immersive eight-week experience in opthalmology at Mass Eye and Ear and Schepens Eye Research Institute of Mass Eye and Ear...

AMD is the leading cause of vision loss in developed countries, and accounts for 8.7% of visual impairment worldwide. AMD is caused by a combination of genetic and environmental factors with age being the greatest risk factor. In the United States, AMD affects 7 percent of people age 60-69 and 35...

Claes H. Dohlman, MD, PhD Born in 1922 in Sweden, Claes Henrik Dohlman, MD, PhD stands as one of the most highly honored ophthalmologists in the world. Recognized as the founder of modern corneal science, he has produced work that is now considered “classic” literature on understanding corneal...

eye Insights TM Issue 3 focuses on the Boston KPro, specifically on how to manage complications associated with implantation, postoperative treatment guidelines, and new clinical innovations. Eye Insights is a clinical newsletter published by Massachusetts Eye and Ear and Massachusetts General...

Many inherited diseases are caused by mutations in a single gene (Mendelian disorder), and detection of the responsible mutation can predict development of the disease with relatively high accuracy. If your clinical findings suggest the presence of an inherited eye disease, such as those described...

Herpes zoster ophthalmicus (HZO) is reactivation of a varicella zoster virus infection (shingles) involving the eye. In the acute phase, patients present with a dermatomal forehead rash and severe pain around the infected area. Inflammation of anterior segment tissues and, less commonly, posterior...

Dear Colleagues, In this issue of eye Insights, we highlight two treatments for the management of strabismus: botulinum toxin and adjustable sutures. We include indications for their use, techniques to incorporate them into practice, and outcomes. A list of peer-reviewed journal articles is included...